Public health is the science and practice of protecting and improving the health of a community by education, disease and injury prevention, wellness promotion, and health protection. From scientific research to health education, the field of public health strives to improve lives and social conditions that affect the health of a community. It is because of public health that we understand that second-hand smoke can cause cancer, that bicycle helmets can save lives, and that unclean water can carry disease-causing bacteria.
The overall health of a community is affected by social, cultural and economic factors. Health experts explore all aspects of people’s lives in order to fully expose and gauge the multitude of issues that impact community wellness. Public health practitioners are especially qualified as policy advocates and to promote behavioral change and wellness practices.
While medical practitioners are interested in the health of individual patients, public health practitioners are interested in the health of the community as a whole. As former Surgeon General C. Everett Koop wrote, "health care is vital to all of us some of the time, but public health is vital to all of us all of the time." Reports in this category will include those aimed at pharmaceutical marketers and diagnostic marketers or those related to health statistics.
The overall health of a community is affected by social, cultural and economic factors. Health experts explore all aspects of people’s lives in order to fully expose and gauge the multitude of issues that impact community wellness. Public health practitioners are especially qualified as policy advocates and to promote behavioral change and wellness practices. While medical practitioners are interested in the health of individual patients, public health practitioners are interested in the health of the community as a whole. As former Surgeon General C. Everett Koop wrote, "health care is vital to all of us some of the time, but public health is vital to all of us all of the time." Reports in this category will include those aimed at pharmaceutical marketers and diagnostic marketers or those related to health statistics.
All reports in Public Health
|
Community-Acquired Infections - Pipeline Review, H1 2012
1/23/2012 | published by: Global Markets Direct
... for Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community-Acquired Infections. 'Community-Acquired Infections - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Comparative Guide to Health in America
7/1/2011 | published by: Grey House Publishing Inc
... infant mortality to air quality, children in poverty to access to healthcare. This important new reference will offer a comprehensive look at the health of America, from the county level, with detailed profiles, ratings and ...
|
more...
|
$150.00
|
|
The 2011-2016 World Outlook for Government Public Health Activities
1/20/2011 | published by: Icon Group International, Inc.
... country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ...
|
more...
|
$795.00
|
|
H1N1 (Swine Influenza) - Pipeline Review, Q4 2010
12/29/2010 | published by: Global Markets Direct
... on the therapeutic development for H1N1 (Swine Influenza) Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 (Swine Influenza) ...
|
more...
|
$500.00
|
|
Pricing and Reimbursement of Antivirals
6/1/2010 | published by: Decision Resources
... treatments for both chronic and acute viral infections. Faced with growing expenditures on these medicines, governments and other payers are struggling to strike a balance between maintaining public health and preserving their finances. Based on ...
|
more...
|
$4,600.00
|
|
H1N1 "Swine Flu" Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
5/1/2010 | published by: Kalorama Information
... manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths. Who were the companies that performed best in this market? How did goverment contracts play ...
|
more...
|
$1,200.00
|
|
Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009
10/13/2009 | published by: Decision Resources
... be warranted, given that no infectious disease has killed more people in a short period of time than influenza. Without preventive measures-such as vaccines-the current A/H1N1 ("swine flu") 2009 pandemic could claim more than 1 ...
|
more...
|
$9,200.00
|
|
Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
8/6/2009 | published by: Datamonitor
... and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges. Scope Strategic analysis of the current influenza market across the US, Japan, France, Germany, Italy, ...
|
more...
|
$15,200.00
|
|
Seasonal Influenza Vaccines Market Forecast
8/6/2009 | published by: Datamonitor
... and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges. Reasons to Purchase Review the clinical and commercial factors driving new product decisions in influenza ...
|
more...
|
$15,200.00
|
|
The Global Influenza Market
8/1/2009 | published by: BCC Research
... the segments of vaccines/therapeutics and diagnostics. Each market segment discussion provides detailed information based on product categories, use of products, forecasts, and competitive analysis Covers some of the most significant issues, trends and market factors ...
|
more...
|
$4,850.00
|
|
Eclipsys: An HIT First Responder with H1N1 Influenza Toolkit
5/18/2009 | published by: IDC
... United States, Eclipsys released an influenza A H1N1 (swine flu) outcomes toolkit that is designed to help hospitals using its electronic medical record (EMR) to limit the spread of influenza in hospital waiting areas. It ...
|
more...
|
$1,500.00
|
|
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
5/1/2009 | published by: Kalorama Information
... appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both ...
|
more...
|
$250.00
|
|
MarketVIEW: H1N1 vaccine (US demand model)
5/1/2009 | published by: VacZine Analytics
... infection with over half of the cases being identified in the continental United States. Using currently available information regarding the expected profile, possible allocation of H1N1 specific vaccine and predictions of pandemic severity, VacZine Analytics ...
|
more...
|
$1,995.00
|
|
The 2009 Report on Government Public Health Activities: World Market Segmentation by City
5/1/2009 | published by: Icon Group International, Inc.
... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ...
|
more...
|
$795.00
|
|
Research Report Chinese Bird Flu Vaccine Industry, 2009
4/28/2009 | published by: China Research and Intelligence Co., Ltd.
... may be more difficult to deal with those newly-discovered diseases which often result in big disaster for people know little about it. Zoonosis is usually caused by such close contacts between animals and human beings ...
|
more...
|
$1,599.00
|
|
MarketVIEW: pre-pandemic vaccines
3/1/2009 | published by: VacZine Analytics
... has caused high mortality in poultry and occasionally infects humans in close contact with around 60% of cases (408) so far being fatal. As of February 27th 2009 confirmed H5N1 Avian influenza deaths in humans ...
|
more...
|
$8,995.00
|
|
Diseaseinfopack: Pre-pandemic Vaccines
3/1/2009 | published by: VacZine Analytics
... H5N1 Avian influenza deaths in humans have reached 256, a significant increase upon 2004 when measurements began. This expert report provides a comprehensive up-to-date critical review of current global pandemic preparedness and planning with regard ...
|
more...
|
$6,995.00
|
|
Infectious Diseases Vaccine Market Overview: Key Companies & Strategies - In times of crisis, Big Pharma turns to vaccines
12/18/2008 | published by: Datamonitor
... Co's Gardasil, along with the emergence of novel vaccine technologies and favourable legislation have brought vaccines back into the main focus of pharmaceutical and biotech companies. Scope Market overview with current market assessment in terms ...
|
more...
|
$15,200.00
|
|
Binge Drinking & Moderation in Alcoholic Drinks
11/10/2008 | published by: Datamonitor
... report examines consumer attitudes towards alcohol, cultural drinking trends and the importance of promoting responsible drinking at a time when alcohol misuse is attracting widespread negative attention. Scope Detailed insights and analysis documenting alcoholic beverage ...
|
more...
|
$3,995.00
|
|
The Global Anti-Addiction Market, 2008-2023
11/5/2008 | published by: Visiongain
... 2008-2023, provides an in-depth analysis of the current state of the market for addiction therapy drugs, from the present looking forward. It covers the major therapy areas of smoking cessation, obesity, drug addiction and alcohol ...
|
more...
|
$2,331.00
|
|
The 2009-2014 World Outlook for Government Public Health Activities
9/27/2008 | published by: Icon Group International, Inc.
... country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ...
|
more...
|
$795.00
|
|
Disease INFOPACK: Norovirus
9/1/2008 | published by: VacZine Analytics
... the elderly in long-term care facilities and hospitals. Although Noroviruses cause a mild illness of short duration, severe dehydration or electrolyte imbalance can be a contributing cause to death in vulnerable populations. Significantly, current evidence ...
|
more...
|
$4,595.00
|
|
Big World: Impact of the Obesity Pandemic on Global Marketing Strategies
6/1/2008 | published by: Euromonitor International
... This brings together research across the Euromonitor International’s output and weighs up the trends. Euromonitor International strategy briefings alert you to global trends predicted to influence consumer markets. They offer insight to changing market conditions ...
|
more...
|
$2,600.00
|
|
Impact Of Pharmacogenomics On Public Healthcare Policy: Educating Patients, Payors And Healthcare Providers
3/1/2008 | published by: Business Insights
... concept. Pharmacogenomics (PGx) embodies the principles of personalized medicine by combining pharmacology with genetic information to improve drug safety and efficiency. The pharma industry is currently applying PGx throughout its R&D processes to enhance decision ...
|
more...
|
$3,835.00
|
|
Plimsoll Portfolio Analysis - Drug & Alcohol Screening
10/1/2007 | published by: Plimsoll Publishing Ltd.
... your business. Using the most up to date information available, the analysis is ideal both as a tool to benchmark your own company's results and to study the market in more depth. Aimed at the ...
|
more...
|
$600.00
|
